As part of this effort, we investigated the role of a small-molecule inhibitor of the BET family of proteins, GSK1210151A (I-BET151)20,21, in a pre-clinical mouse NASH STAM model22 to assess its efficacy against NASH and hepatic fibrosis. This evidence concerns the gene DNER and metabolic dysfunction-associated steatohepatitis.